{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:42:51Z","timestamp":1792701771317,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["0315562"],"award-info":[{"award-number":["0315562"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03EFEBW084"],"award-info":[{"award-number":["03EFEBW084"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jconrel.2016.06.022","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T02:15:18Z","timestamp":1466129718000},"page":"379-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity"],"prefix":"10.1016","volume":"235","author":[{"given":"L.","family":"Krutzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Prill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.Q.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Simmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kreppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.06.022_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002281","article-title":"Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium","volume":"7","author":"Ganesan","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0010","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"Mast","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0020","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1089\/hum.1998.9.14-2121","article-title":"Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma","volume":"9","author":"Molnar-Kimber","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0030","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0035","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0040","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1525-0016(02)00017-5","article-title":"Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors","volume":"7","author":"Schiedner","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymthe.2005.06.477","article-title":"Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer","volume":"13","author":"Snoeys","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0060","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2006-04-008532","article-title":"Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes","volume":"108","author":"Parker","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0070","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0075","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.gt.3301961","article-title":"Titer determination of Ad5 in blood: a cautionary note","volume":"10","author":"Cichon","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000277","article-title":"The cell adhesion molecule \u201cCAR\u201d and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution","volume":"5","author":"Seiradake","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0085","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1099\/vir.0.83495-0","article-title":"Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages","volume":"89","author":"Haisma","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0090","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/jvi.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors","volume":"71","author":"Lieber","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/jvi.71.1.624-629.1997","article-title":"Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ","volume":"71","author":"Wolff","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0105","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.05760-11","article-title":"Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors","volume":"86","author":"Khare","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imbio.2004.02.004","article-title":"The role of scavenger receptors in pathogen recognition and innate immunity","volume":"209","author":"Mukhopadhyay","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mt.2012.287","article-title":"SR-A and SREC-I are Kupffer and endothelial cell receptors for helper-dependent adenoviral vectors","volume":"21","author":"Piccolo","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0120","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/mt.2011.71","article-title":"Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer","volume":"19","author":"Khare","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0125","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/hum.2005.16.1346","article-title":"Serotype specificity of adenovirus purification using anion-exchange chromatography","volume":"16","author":"Konz","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0130","doi-asserted-by":"crossref","first-page":"e1004673","DOI":"10.1371\/journal.ppat.1004673","article-title":"Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo","volume":"11","author":"Ma","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0135","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/10430340050111368","article-title":"Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions","volume":"11","author":"Croyle","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0140","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0145","doi-asserted-by":"crossref","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","article-title":"Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X","volume":"6","author":"Bradshaw","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0150","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","article-title":"Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors","volume":"116","author":"Alba","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0155","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.gt.3302295","article-title":"Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus","volume":"11","author":"Green","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0160","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.mt.6300306","article-title":"Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies","volume":"16","author":"Wortmann","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","article-title":"Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses","volume":"11","author":"Mok","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.gt.3301389","article-title":"Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies","volume":"8","author":"Fisher","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymthe.2005.03.006","article-title":"Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors","volume":"12","author":"Kreppel","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0185","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/JVI.74.6.2804-2813.2000","article-title":"Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein","volume":"74","author":"Kirby","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0190","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1089\/104303400750001417","article-title":"Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production","volume":"11","author":"Schiedner","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mt.2010.229","article-title":"Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells","volume":"19","author":"Prill","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0205","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1089\/104303402320138934","article-title":"A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations","volume":"13","author":"Kreppel","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/elps.1150080203","article-title":"Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels","volume":"8","author":"Blum","year":"1987","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0215","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus","volume":"5","author":"Chen","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082716","article-title":"Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo","volume":"9","author":"Prill","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1743-422X-9-265","article-title":"Evaluation of nanoparticle tracking analysis for total virus particle determination","volume":"9","author":"Kramberger","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0230","series-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2012"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085432","article-title":"Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus","volume":"9","author":"Unzu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0240","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.01392-12","article-title":"Circulating antibodies and macrophages as modulators of adenovirus pharmacology","volume":"87","author":"Khare","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0245","article-title":"Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors","author":"Qiu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0255","series-title":"Privigen \u2014 Immune Globulin Intravenous (Human), 10% Liquid","author":"Chrvala","year":"2011"},{"key":"10.1016\/j.jconrel.2016.06.022_bb0260","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/JVI.01939-15","article-title":"Hepatocyte heparan sulfate is required for adeno-associated virus 2 but dispensable for adenovirus 5 liver transduction in vivo","volume":"90","author":"Zaiss","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.06.022_bb0270","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/hum.2009.171","article-title":"Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications","volume":"21","author":"Espenlaub","year":"2010","journal-title":"Hum. Gene Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591630387X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591630387X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:37:18Z","timestamp":1785775038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591630387X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":53,"alternative-id":["S016836591630387X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.022","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}